The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years

BACKGROUND: Evidence-based guidelines for follow-up treatment of American Joint Committee on Cancer (AJCC) stages 1B to 2C melanoma patients are lacking. The MELanoma FOllow-up study is an international phase 3 randomized trial, and the 3-year interim data were recently reported from the Netherlands...

Descripción completa

Detalles Bibliográficos
Autores principales: Moncrieff, Marc D., Underwood, Beverly, Garioch, Jennifer J., Heaton, Martin, Patel, Nakul, Bastiaannet, Esther, Hoekstra-Weebers, Josette E. H. M., Hoekstra, Harald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Melanoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497689/
https://www.ncbi.nlm.nih.gov/pubmed/32623608
http://dx.doi.org/10.1245/s10434-020-08758-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497689/
https://www.ncbi.nlm.nih.gov/pubmed/32623608
http://dx.doi.org/10.1245/s10434-020-08758-2

Ejemplares similares